CLINICAL_TRIALS
trial_result
· 2021-02-26
Clinical Trial Update: Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus [Phase 3]
Summary
Phase 3 randomized trial of rivoglitazone in type 2 diabetes mellitus was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: TERMINATED | Results posted: 2021-02-26